News Releases

May 22, 2019 5/22/2019 Entyvio® (vedolizumab) Approved in Japan for the Treatment of Patients with Moderately to Severely Active Crohn's Disease

May 19, 2019 5/19/2019 New Exploratory Data from VARSITY Presented at 2019 Digestive Disease Week

May 16, 2019 5/16/2019 Takeda to Showcase Growing Pipeline and Diversified Portfolio of Oncology Products at Upcoming Scientific Congresses

May 16, 2019 5/16/2019 Takeda and London School of Hygiene & Tropical Medicine Establish "Takeda Chair in Global Child Health"

May 15, 2019 5/15/2019 Takeda to Highlight New Research into the Long-term Complications of Chronic Hypoparathyroidism at the European Congress of Endocrinology 2019 Annual Meeting

May 14, 2019 5/14/2019 Continuation of and Partial Revisions to the Long-Term Incentive Plan for Members of the Board of Directors in Fiscal 2019

May 14, 2019 5/14/2019 Continuation of Stock Grant System (Global Long-Term Incentive Plan) for Company Group Management in Japan and Overseas in Fiscal 2019

May 14, 2019 5/14/2019 Notice Concerning Issuance of New Stocks through Third-Party

May 14, 2019 5/14/2019 Takeda Announces Candidates for New Directors

May 2019